By Fineline Cube 
France-based Ipsen S.A. (EPA: IPN, OTCMKTS: IPSEY) announced the signing of a cooperation agreement with China-based Shanghai Pharmaceuticals Holding Ltd (SPH, HKG: 2607, SHA: 601607) . The partnership aims to integrate resources and expand channel coverage to promote the in-depth market penetration of Diphereline (triptorelin) in China.
About Diphereline
Diphereline is a widely used gonadotropin-releasing hormone (GnRH) product. It has been extensively applied in the treatment of various conditions, including prostate cancer, central precocious puberty, endometriosis, female infertility, and preoperative treatment of uterine fibroids. This collaboration is expected to enhance the availability and accessibility of Diphereline in the Chinese market.-Fineline Info & Tech